CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleLevered free cash flow is $20.63M, above the global median of $16.24M
- PositionDebt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.84%
Annual Rate
CNY 0.20Paid annual
Payout Ratio
19.5%Sustainable
Payback Period
54.6 yr
Last Ex-Dividend
Jul 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.88BCNY725.94M · vs all stocks (USD)
Trailing P/E
30.84xvs Medical Instruments & Supplies peers
Revenue (TTM)
847.27MCNY126.00M · vs all stocks (USD)
Profit Margin
19.28%vs Medical Instruments & Supplies peers
Beta
0.4800xvs all stocks
52-Week Change
-6.12%vs all stocks
Market Capitalization
4.88BCNY725.94M · vs all stocks (USD)
Enterprise Value
3.65BCNY543.29M · vs all stocks (USD)
Trailing P/E
30.84xvs Medical Instruments & Supplies peers
Forward P/E
16.75xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
6.03xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.78xvs Medical Instruments & Supplies peers
Enterprise to Revenue
4.31xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
18.05xvs Medical Instruments & Supplies peers
Gross Margin
55.11%vs Medical Instruments & Supplies peers
Profit Margin
19.28%vs Medical Instruments & Supplies peers
Operating Margin
25.52%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
5.18%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
9.11%vs Medical Instruments & Supplies peers
Revenue (TTM)
847.27MCNY126.00M · vs all stocks (USD)
Revenue per Share (TTM)
1.90CNYUpdated Aug 21, 2026Quarterly Revenue Growth
21.30%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
433.80MCNY64.51M · vs all stocks (USD)
EBITDA (TTM)
185.43MCNY27.57M · vs all stocks (USD)
Net Income (TTM)
163.36MCNY24.29M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
47.20%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
301.65MCNY44.86M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
138.70MCNY20.63M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2000CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
1.84%vs all stocks
Payout Ratio
19.49%vs Medical Instruments & Supplies peers
Revenue
806.91MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
401.59MCNYFY2025 · Dec 31, 2025Gross Profit
405.32MCNYFY2025 · Dec 31, 2025Operating Income
183.15MCNY27.24M · vs all stocks (USD)
Pre-tax Income
164.75MCNYFY2025 · Dec 31, 2025Income Tax Expense
20.51MCNYFY2025 · Dec 31, 2025Net Income
144.24MCNYFY2025 · Dec 31, 2025EBIT
165.03MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
201.99MCNYFY2025 · Dec 31, 2025Research & Development
62.78MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
67.36MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.57MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
7.03MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
275.13KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4589CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4589CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
317.90MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
317.90MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
144.24MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
1.64MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
86.40MCNYFY2025 · Dec 31, 2025Free Cash Flow
-68.82MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
771.98MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
144.24MCNYFY2025 · Dec 31, 2025Other Non-cash Items
2.35MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-19.60MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-40.60MCNYFY2025 · Dec 31, 2025Capital Expenditures
-155.22MCNYFY2025 · Dec 31, 2025Purchase of Investments
-124.40MCNYFY2025 · Dec 31, 2025Sale of Investments
18.02MCNYFY2025 · Dec 31, 2025Other Investing Activity
16.00CNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-261.60MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-31.96MCNYFY2025 · Dec 31, 2025Other Financing Charges
-16.59MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-48.55MCNYFY2025 · Dec 31, 2025Shares Outstanding
447.44MSharesUpdated Aug 21, 2026Float Shares
185.66MSharesUpdated Aug 21, 2026% Held by Insiders
44.73%vs all stocks
% Held by Institutions
19.01%vs all stocks
Total Cash (MRQ)
1.45BCNY215.87M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.25CNYUpdated Aug 21, 2026Total Debt (MRQ)
1.68MCNY249.70K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0009xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
4.12xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
4.10CNYUpdated Aug 21, 2026Total Assets
2.35BCNY348.98M · vs all stocks (USD)
Total Current Assets
1.85BCNYFY2025 · Dec 31, 2025Total Liabilities
567.74MCNYFY2025 · Dec 31, 2025Total Non-current Assets
498.53MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
110.48MCNYFY2025 · Dec 31, 2025Total Current Liabilities
457.27MCNYFY2025 · Dec 31, 2025Cash
551.83MCNYFY2025 · Dec 31, 2025Cash Equivalents
21.06MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
572.88MCNYFY2025 · Dec 31, 2025Other Short-term Investments
941.03MCNYFY2025 · Dec 31, 2025Accounts Receivable
112.17MCNYFY2025 · Dec 31, 2025Inventory
184.73MCNYFY2025 · Dec 31, 2025Accounts Payable
217.82MCNYFY2025 · Dec 31, 2025Short-term Debt
1.35MCNYFY2025 · Dec 31, 2025Other Current Liabilities
4.33MCNYFY2025 · Dec 31, 2025Long-term Debt
732.63KCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
37.48MCNYFY2025 · Dec 31, 2025Common Stock (Book)
319.60MCNYFY2025 · Dec 31, 2025Retained Earnings
289.41MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.78BCNY264.55M · vs all stocks (USD)
Treasury Stock
19.90MCNYFY2025 · Dec 31, 202552-Week Low
9.31CNYUpdated Aug 21, 202652-Week High
13.19CNYUpdated Aug 21, 202652-Week Change
-6.12%vs all stocks
Beta
0.4800xvs all stocks
50-Day MA
10.63CNYUpdated Aug 21, 2026200-Day MA
11.23CNYUpdated Aug 21, 2026Avg 10-Day Volume
10.38MSharesUpdated Aug 21, 2026Avg 30-Day Volume
11.19MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.3700CNYUpdated Aug 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
Is this company growing?
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)Notable
Debt-to-equity: 0.00Industry median: 0.23Industry P5: 0.00Peers compared: 65.00
Financial Health
Altman Z-Score 6.62: safe zoneNotable
Altman Z-Score: 6.62
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is $20.63M, above the global median of $16.24MNotable
Levered free cash flow (USD): 20,625,917.583Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Stx Engine Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Zhejiang Entive Smart Kitchen Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Sakata INX Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Yasha Decoration Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Barco NV
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Guangdong Leary New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Yangzhou Seashine New Materials Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Suprajit Engineering Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Dongguan Golden Sun Abrasives Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sichuan Goldstone Asia Pharmaceutical Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Novoray Corp.
3 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityMulti-Year Revenue And Profit GrowthUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Hebei Sinopack Electronic Co., Ltd.
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Wave Life Sciences Ltd.
2 interpretationsMulti-Year Debt Decrease With Cash Near Total Debt And EquityUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated